Cannabis-based medicines

Cannabis-based medicines- a pharmacy guide

From the 1st November 2018 the law changes widening access to cannabis-based products for medicinal use in humans in England, Scotland and Wales. (See The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 ).

Cannabis-based product for medicinal use in humans’ can be available for medicinal use if:

  1. it meets the definition of ‘cannabis-based product for medicinal use in humans’; and
  2. it is accessed through one of the three routes available.

  Member only content

Become a Royal Pharmaceutical Society member to view this content.